PULMONARY NEOPLASMS

Clinical trials for PULMONARY NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new PULMONARY NEOPLASMS trials appear

Sign up with your email to follow new studies for PULMONARY NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New drug targets 'Undruggable' cancer mutation in lung and colon tumors

Disease control Ongoing

This study is testing a new drug called JDQ443, both alone and in combination with other treatments, for patients with advanced solid tumors that have a specific genetic change called KRAS G12C. The main goals are to find safe doses and see if the treatments can shrink tumors. It…

Matched conditions: PULMONARY NEOPLASMS

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

PULMONARY NEOPLASMS

Get alerted when new PULMONARY NEOPLASMS trials appear

New drug targets 'Undruggable' cancer mutation in lung and colon tumors